DRKS00010797
Not yet recruiting
未知
Improvement of the Patientenadherence and avoidance of side effects by one special speech hour for oral tumour therapy
Onkologisch-palliativmedizinisches Netzwerk Landshut0 sites100 target enrollmentJuly 14, 2016
ConditionsD47.4C90.0PATIENTENADHERENCE QUALITY OF LIFE CURVESTOXICITYCURVE NCI CTC Version 4.0 HOSPITALISATIONS DOCTOR'S CONTACTSC18C19C20C50C34C64C43C83.1C91.1C82D45C92.1Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectumMalignant neoplasm of breastMalignant neoplasm of bronchus and lungMalignant neoplasm of kidney, except renal pelvisMalignant melanoma of skinMantle cell lymphomaChronic lymphocytic leukaemia of B-cell typeFollicular lymphomaMultiple myelomaOsteomyelofibrosisPolycythaemia veraChronic myeloid leukaemia [CML], BCR/ABL-positive
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- D47.4
- Sponsor
- Onkologisch-palliativmedizinisches Netzwerk Landshut
- Enrollment
- 100
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •inclusion criteria
- •All patients in whom a secured hematologic or oncologic disease following entity exists and which are treated with an oral anti\-proliferative therapy :
- •Colorektaleskarzinom
- •breast cancer
- •Non small cell lung cancer ( adenocarcinoma )
- •Renal Cell Carcinoma
- •Malignant melanoma
- •Mantle cell lymphoma
- •Chronic Lymphocytic Leukemia
- •follicular lymphoma
Exclusion Criteria
- •Lack of ability to independently tablets
- •Lack of knowledge of German or lack of ability to autonomously understand and fill out the applications described in the study questionnaires
- •Missing or limited legal capacity
- •Participation in another clinical trial with not yet approved substances
- •Any significant concomitant disease that excludes the participation of the patient in the study of the investigator 's opinion
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Increasing medication adherence to improve patient´s safety in cardiological rehabilitatiomedication adherenceE10-E14I10-I15Diabetes mellitusHypertensive diseasesDRKS00011134Medizinische Fakultät, Medizinische Psychologie und Medizinische Soziologie886
Completed
Not Applicable
Tailored interventions to improve adherence to medication in elderly patients with Parkinson’s disease: a randomized controlled trialon-AdherenceG20Parkinson diseaseDRKS00023655Department of Neurology, Jena University Hospital132
Recruiting
Not Applicable
Effects of a Behavioural Program to Improve Diabetes Care and Health Outcomes in Young Adults with Type 1 DiabetesType 1 DiabetesMetabolic and Endocrine - DiabetesACTRN12610000686000Dr Melanie Burkhardt45
Withdrawn
Not Applicable
Improving treatment adherence in chronically ill adolescents and young adults.NL-OMON46629Academisch Medisch Centrum500
Active, not recruiting
Not Applicable
Improving medication adherence and satisfaction with pharmacist-provided services for heart failure patients using a risk management dashboardISRCTN13218468ational Taiwan University Hospital70